Exane Derivatives’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Exane Derivatives’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	-$1.94K	–	714
2019 Q3	$1.94K	Hold	20	–	–	﹤0.01%	492
2019 Q2	$2.05K	Hold	20	–	–	﹤0.01%	506
2019 Q1	$2.28K	Hold	20	–	–	﹤0.01%	435
2018 Q4	$783	Hold	20	–	–	﹤0.01%	580
2018 Q3	$1.09K	Sell	20 -2,078	-99%	-$142K	﹤0.01%	529
2018 Q2	$175K	Hold	2,098	–	–	0.03%	277
2018 Q1	$136K	Buy	+2,098	New	+$121K	0.03%	265

Exane Derivatives's ONCE Position: Q4 2019 in Review

Exane Derivatives sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 20 shares — an estimated $1.94K sold.

Exane Derivatives first reported a position in ONCE in Q1 2018 and held it in 7 quarters. The position peaked at $175K in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Exane Derivatives reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Exane Derivatives sold 20 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.94K.
Exane Derivatives first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Exane Derivatives's Spark Therapeutics, Inc. Common Stock position peaked at $175K in Q2 2018.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.